When singer Muni Long isn’t blessing us with timeless hits, she’s struggling with lupus pain behind closed doors. The chronic ...

For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard ...

People often fail to acknowledge the type of grief that comes with chronic illness. It's time to change that, columnist ...

In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.

Anifrolumab (brand name Saphnelo) reduced the risk of long-term organ damage progression by about 60% in patients with ...

A benefit concert and talent show fundraiser is slated for Saturday, March 1, as the Lupus Foundation of Arkansas continue to ...

Despite being a rare disease, lupus is a leading cause of death for women under the age of 35 with Black women experiencing more severe symptoms and higher mortality rates compared to other groups.

The following is a summary of “Dual seropositive nonerosive lupus arthritis: rhupus or not?” published in the February 2025 ...

Adding obinutuzumab to standard therapy for active lupus nephritis led to significantly higher rates of complete renal ...

The Grammy-award winner was diagnosed with lupus in 2014 Nathan Vinson is the Weekend Audience Editor for PEOPLE.com, where he oversees PEOPLE's social media channels, newsletters and ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...